Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (168)

2024

  1. Clinical Features and Disease Activity in Psoriatic Arthritis: A Sex-Related Perspective on Leptin and Comorbidity

    Journal of Clinical Medicine, Vol. 13, Núm. 10

  2. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 6, pp. 706-719

  3. HLA-C*06–defined endotype in psoriatic disease: an ever-widening landscape

    Rheumatology (United Kingdom)

  4. Influence of comorbidities not associated with fibromyalgia on neuropathic pain in patients with psoriatic arthritis: relationship with clinical parameters

    Frontiers in Medicine, Vol. 11

  5. Influence of the HLA-Cw6 Allele and IFIH1/MDA5 Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic Disease

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  6. Reply to: The association between sex and disease impact cannot be confounded by clinical risk factors

    Clinical and Experimental Rheumatology

  7. Ultrasound in Psoriatic Arthritis: Still Many Pending Issues

    Journal of Rheumatology

2023

  1. Altered sleep in axial spondyloarthritis and psoriatic arthritis: Post hoc comparative study based on a sleep-specific question from the ASAS health index

    Reumatologia Clinica, Vol. 19, Núm. 8, pp. 430-435

  2. An International Multidisciplinary Delphi-Based Consensus on Heat Therapy in Musculoskeletal Pain

    Pain and Therapy, Vol. 12, Núm. 1, pp. 93-110

  3. Are Patients with Axial Spondyloarthritis Who Were Breastfed Protected against the Development of Severe Disease?

    Journal of Clinical Medicine, Vol. 12, Núm. 5

  4. Bimekizumab in psoriatic arthritis: a great leap forward?

    The Lancet

  5. Correction to: An International Multidisciplinary Delphi-Based Consensus on Heat Therapy in Musculoskeletal Pain (Pain and Therapy, (2023), 12, 1, (93-110), 10.1007/s40122-022-00419-4)

    Pain and Therapy

  6. Corrigendum: The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases(Front. Immunol., (2023), 14, (1191782), 10.3389/fimmu.2023.1191782)

    Frontiers in Immunology

  7. Differentiated Effect of Smoking on Disease Activity and Quality of Life among Different Spondyloarthritis Phenotypes

    Journal of Clinical Medicine, Vol. 12, Núm. 2

  8. Does pharmacological intervention prevent or delay the onset of psoriatic arthritis among psoriasis patients?

    Expert Opinion on Biological Therapy

  9. EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 9, pp. 1162-1170

  10. Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile

    Frontiers in Immunology, Vol. 14

  11. Managing psoriatic arthritis in different clinical scenarios

    Expert Review of Clinical Immunology, Vol. 19, Núm. 12, pp. 1469-1484

  12. Osteomalacia in Adults: A Practical Insight for Clinicians

    Journal of Clinical Medicine, Vol. 12, Núm. 7

  13. PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis

    Rheumatology and Therapy, Vol. 10, Núm. 2, pp. 489-505